Pricing Log in Create free account

eXoZymes Inc. (EXOZ) vs Pelthos Therapeutics Inc. (PTHS)

eXoZymes Inc. and Pelthos Therapeutics Inc. are both Biotechnology companies. eXoZymes Inc. and Pelthos Therapeutics Inc. are of similar size ($38.1M and $35.6M). eXoZymes Inc. has the higher net margin (0.00% vs −199.5%) and the higher return on invested capital (0.00% vs −82.3%). Across the 12 metrics below, eXoZymes Inc. leads on 9 and Pelthos Therapeutics Inc. on 3.

Valuation

Metric EXOZ PTHS Biotechnology median
P/E n/m n/m 10.60
P/S n/m 0.78 9.40
P/B 10.43 n/m 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales n/m 1.88 9.02
Earnings yield (27.05%) (276.23%) (32.88%)
Free cash flow yield (18.74%) (126.55%) (23.13%)

Profitability

Metric EXOZ PTHS Biotechnology median
Gross margin — 78.59% 68.51%
Operating margin 0.00% (133.42%) 0.00%
Net margin 0.00% (199.50%) 0.00%
Free cash flow margin 0.00% (98.37%) 0.00%
Return on equity (187.16%) 2,161.07% (51.96%)
Return on assets (115.42%) (125.04%) (46.06%)
Return on invested capital 0.00% (82.34%) 0.00%

Growth

Metric EXOZ PTHS Biotechnology median
Revenue growth (TTM) — — 6.76%
EPS growth (last fiscal year) (22.47%) (61.12%) 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR — — 0.00%

Health

Metric EXOZ PTHS Biotechnology median
Debt to equity 0.01 (46.58) 0.00
Current ratio 3.81 1.98 4.97
Net debt to EBITDA 0.31 (0.45) 1.01

Dividend

Metric EXOZ PTHS Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric EXOZ PTHS Biotechnology median
Market cap 38.14m 35.61m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack